Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 107

    1.

    Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies.

    Peerschke EI, Yin W, Alpert DR, Roubey RA, Salmon JE, Ghebrehiwet B.

    Lupus. 2009 May;18(6):530-8.PMID: 19395455 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction.

    Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, Crow MK, Sammaritano L, Levine DM, Salmon JE.

    Arthritis Rheum. 2009 Jan;60(1):22-9.PMID: 19116901 [PubMed - indexed for MEDLINE]Related articles

    3.

    Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.

    Salmon JE, Roman MJ.

    Am J Med. 2008 Oct;121(10 Suppl 1):S3-8. Review.PMID: 18926167 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Complement activation fragment Bb in early pregnancy and spontaneous preterm birth.

    Lynch AM, Gibbs RS, Murphy JR, Byers T, Neville MC, Giclas PC, Salmon JE, Van Hecke TM, Holers VM.

    Am J Obstet Gynecol. 2008 Oct;199(4):354.e1-8.PMID: 18928972 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation.

    Salmon JE, Girardi G.

    Trans Am Clin Climatol Assoc. 2007;118:99-114.PMID: 18528494 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pathogenic role of antiphospholipid antibodies.

    Salmon JE, de Groot PG.

    Lupus. 2008;17(5):405-11. Review.PMID: 18490417 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A time capsule for rheumatology.

    Christian CL, Salmon JE, Bucala R.

    Arthritis Rheum. 2008 Feb;58(2 Suppl):S34-8. No abstract available. PMID: 18240264 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.

    Belostocki K, Pricop L, Redecha PB, Aydin A, Leff L, Harrison MJ, Salmon JE.

    Arthritis Rheum. 2008 Feb;58(2):384-8.PMID: 18240208 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia.

    Lynch AM, Murphy JR, Byers T, Gibbs RS, Neville MC, Giclas PC, Salmon JE, Holers VM.

    Am J Obstet Gynecol. 2008 Apr;198(4):385.e1-9. Epub 2008 Jan 25.PMID: 18221926 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Insoluble immune complexes are most effective at triggering IL-10 production in human monocytes and synergize with TLR ligands and C5a.

    DiMartino SJ, Yuan W, Redecha P, Ivashkiv LB, Salmon JE.

    Clin Immunol. 2008 Apr;127(1):56-65. Epub 2008 Jan 16.PMID: 18201931 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cardiovascular manifestations of rheumatologic diseases.

    Roman MJ, Salmon JE.

    Circulation. 2007 Nov 13;116(20):2346-55. Review. No abstract available. PMID: 17998471 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.

    Roman MJ, Crow MK, Lockshin MD, Devereux RB, Paget SA, Sammaritano L, Levine DM, Davis A, Salmon JE.

    Arthritis Rheum. 2007 Oct;56(10):3412-9.PMID: 17907140 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The clinical and public health value of non-culture methods in the investigation of a cluster of unexplained pneumonia cases.

    Sheppard CL, Salmon JE, Harrison TG, Lyons M, George RC.

    Epidemiol Infect. 2008 Jul;136(7):922-7. Epub 2007 Aug 16.PMID: 17697442 [PubMed - indexed for MEDLINE]Related articles

    14.

    Subclinical carotid atherosclerosis in a patient with systemic lupus erythematosus.

    Alpert D, Davis A, Erkan D, Roman MJ, Salmon JE.

    Nat Clin Pract Rheumatol. 2007 Aug;3(8):473-8; quiz, 2nd following 478.PMID: 17664955 [PubMed - indexed for MEDLINE]Related articles

    15.

    Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.

    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.

    Ann Rheum Dis. 2008 Mar;67(3):395-401. Epub 2007 Jul 20.PMID: 17644539 [PubMed - indexed for MEDLINE]Related articles

    16.

    Systemic lupus erythematosus predicts increased left ventricular mass.

    Pieretti J, Roman MJ, Devereux RB, Lockshin MD, Crow MK, Paget SA, Schwartz JE, Sammaritano L, Levine DM, Salmon JE.

    Circulation. 2007 Jul 24;116(4):419-26. Epub 2007 Jul 9.PMID: 17620509 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury.

    Redecha P, Tilley R, Tencati M, Salmon JE, Kirchhofer D, Mackman N, Girardi G.

    Blood. 2007 Oct 1;110(7):2423-31. Epub 2007 May 29.PMID: 17536017 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers.

    Sood R, Zogg M, Westrick RJ, Guo YH, Kerschen EJ, Girardi G, Salmon JE, Coughlin SR, Weiler H.

    J Exp Med. 2007 May 14;204(5):1049-56. Epub 2007 Apr 16.PMID: 17438064 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation.

    Salmon JE, Girardi G.

    J Reprod Immunol. 2008 Jan;77(1):51-6. Epub 2007 Apr 5. Review.PMID: 17418423 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients.

    Salmon JE, Girardi G, Lockshin MD.

    Nat Clin Pract Rheumatol. 2007 Mar;3(3):140-7; quiz 1 p following 187. Review.PMID: 17334336 [PubMed - indexed for MEDLINE]Related articles

    21.

    Autoantibody selection and production in early human life.

    Meffre E, Salmon JE.

    J Clin Invest. 2007 Mar;117(3):598-601.PMID: 17332890 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.

    Shamonki JM, Salmon JE, Hyjek E, Baergen RN.

    Am J Obstet Gynecol. 2007 Feb;196(2):167.e1-5.PMID: 17306667 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.

    Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE.

    Arthritis Rheum. 2006 Dec;54(12):3918-25.PMID: 17133599 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.

    Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE.

    J Exp Med. 2006 Sep 4;203(9):2165-75. Epub 2006 Aug 21.PMID: 16923853 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Are we coming to terms with tumor necrosis factor inhibition in pregnancy?

    Salmon JE, Alpert D.

    Arthritis Rheum. 2006 Aug;54(8):2353-5. No abstract available. PMID: 16868990 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Soluble mediators as therapeutic targets in systemic lupus erythematosus: cytokines, immunoglobulin receptors, and the complement system.

    Kirou KA, Salmon JE, Crow MK.

    Rheum Dis Clin North Am. 2006 Feb;32(1):103-19, ix. Review.PMID: 16504824 [PubMed - indexed for MEDLINE]Related articles

    27.

    Preclinical carotid atherosclerosis in patients with rheumatoid arthritis.

    Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD, Sammaritano L, Devereux RB, Schwartz JE, Levine DM, Salmon JE.

    Ann Intern Med. 2006 Feb 21;144(4):249-56. Erratum in: Ann Intern Med. 2006 Dec 5;145(11):868. PMID: 16490910 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase.

    Mineo C, Gormley AK, Yuhanna IS, Osborne-Lawrence S, Gibson LL, Hahner L, Shohet RV, Black S, Salmon JE, Samols D, Karp DR, Thomas GD, Shaul PW.

    Circ Res. 2005 Nov 25;97(11):1124-31. Epub 2005 Nov 3.PMID: 16269657 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    FcgammaRIIa is a target for modulation by TNFalpha in human neutrophils.

    Belostocki K, Park MS, Redecha PB, Masuda E, Salmon JE, Pricop L.

    Clin Immunol. 2005 Oct;117(1):78-86.PMID: 16084773 [PubMed - indexed for MEDLINE]Related articles

    30.

    The complement system in the pathophysiology of pregnancy.

    Girardi G, Bulla R, Salmon JE, Tedesco F.

    Mol Immunol. 2006 Jan;43(1-2):68-77. Review.PMID: 16023727 [PubMed - indexed for MEDLINE]Related articles

    31.

    Arterial stiffness in chronic inflammatory diseases.

    Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, Davis A, Crow MK, Sammaritano L, Levine DM, Shankar BA, Moeller E, Salmon JE.

    Hypertension. 2005 Jul;46(1):194-9. Epub 2005 May 23.PMID: 15911740 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    The use of LMWH in pregnancies at risk: new evidence or perception?

    Walker ID, Kujovich JL, Greer IA, Rey E, David M, Salmon JE, Hunt BJ, Zotz RB, Gerhardt A, Scharf RE, Middeldorf S, Martinelli I, Cetin I, Grandone E.

    J Thromb Haemost. 2005 Apr;3(4):778-93. No abstract available. PMID: 15842362 [PubMed - indexed for MEDLINE]Related articles

    33.

    TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss.

    Berman J, Girardi G, Salmon JE.

    J Immunol. 2005 Jan 1;174(1):485-90.PMID: 15611274 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.

    Girardi G, Redecha P, Salmon JE.

    Nat Med. 2004 Nov;10(11):1222-6. Epub 2004 Oct 17.PMID: 15489858 [PubMed - indexed for MEDLINE]Related articles

    35.

    A noninflammatory pathway for pregnancy loss: innate immune activation?

    Salmon JE.

    J Clin Invest. 2004 Jul;114(1):15-7. Review.PMID: 15232605 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    The role of complement in the antiphospholipid syndrome.

    Salmon JE, Girardi G.

    Curr Dir Autoimmun. 2004;7:133-48. Review.PMID: 14719378 [PubMed - indexed for MEDLINE]Related articles

    37.

    Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

    Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE.

    N Engl J Med. 2003 Dec 18;349(25):2399-406. Erratum in: N Engl J Med. 2006 Oct 19;355(16):1746. PMID: 14681505 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.

    Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA, Lambris JD, Holers VM, Salmon JE.

    J Clin Invest. 2003 Dec;112(11):1644-54. Erratum in: J Clin Invest. 2004 Feb;113(4):646. PMID: 14660741 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Activation of complement mediates antiphospholipid antibody-induced pregnancy loss.

    Salmon JE, Girardi G, Holers VM.

    Lupus. 2003;12(7):535-8.PMID: 12892394 [PubMed - indexed for MEDLINE]Related articles

    40.

    Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis.

    Karassa FB, Bijl M, Davies KA, Kallenberg CG, Khamashta MA, Manger K, Michel M, Piette JC, Salmon JE, Song YW, Tsuchiya N, Yoo DH, Ioannidis JP.

    Arthritis Rheum. 2003 Jul;48(7):1930-8.PMID: 12847687 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis.

    Ji JD, Tassiulas I, Park-Min KH, Aydin A, Mecklenbrauker I, Tarakhovsky A, Pricop L, Salmon JE, Ivashkiv LB.

    J Exp Med. 2003 Jun 2;197(11):1573-83.PMID: 12782719 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles.

    Zuniga R, Markowitz GS, Arkachaisri T, Imperatore EA, D'Agati VD, Salmon JE.

    Arthritis Rheum. 2003 Feb;48(2):460-70.PMID: 12571856 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Amplified fragment length polymorphism (AFLP) analysis of Clostridium novyi, C. perfringens and Bacillus cereus isolated from injecting drug users during 2000.

    McLauchlin J, Salmon JE, Ahmed S, Brazier JS, Brett MM, George RC, Hood J.

    J Med Microbiol. 2002 Nov;51(11):990-1000.PMID: 12448684 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Isolation and identification of Clostridium spp. from infections associated with the injection of drugs: experiences of a microbiological investigation team.

    Brazier JS, Duerden BI, Hall V, Salmon JE, Hood J, Brett MM, McLauchlin J, George RC.

    J Med Microbiol. 2002 Nov;51(11):985-9.PMID: 12448683 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    An outbreak of serious illness and death among injecting drug users in England during 2000.

    Jones JA, Salmon JE, Djuretic T, Nichols G, George RC, Gill ON, Brazier JS, Brett MM, Duerden BI, Fry NK, Hall V, Hope V, Lieftucht A, McLauchlin J, Pitcher DG, Weild A.

    J Med Microbiol. 2002 Nov;51(11):978-84.PMID: 12448682 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users.

    McGuigan CC, Penrice GM, Gruer L, Ahmed S, Goldberg D, Black M, Salmon JE, Hood J.

    J Med Microbiol. 2002 Nov;51(11):971-7.PMID: 12448681 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.

    Salmon JE, Girardi G, Holers VM.

    Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii46-50. Review. No abstract available. PMID: 12379621 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Characterization of the FcgammaRIIA promoter and 5'UTR sequences in patients with systemic lupus erythematosus.

    Pricop L, Li L, Salmon JE, Jacob CO.

    Genes Immun. 2002 Oct;3 Suppl 1:S47-50.PMID: 12215902 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus.

    Edberg JC, Langefeld CD, Wu J, Moser KL, Kaufman KM, Kelly J, Bansal V, Brown WM, Salmon JE, Rich SS, Harley JB, Kimberly RP.

    Arthritis Rheum. 2002 Aug;46(8):2132-40.PMID: 12209518 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Redox regulation of Fcgamma receptor-mediated phagocytosis: implications for host defense and tissue injury.

    Pricop L, Salmon JE.

    Antioxid Redox Signal. 2002 Feb;4(1):85-95. Review.PMID: 11970846 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...